Losartan reduces the costs of diabetic end‐stage renal disease: An Asian perspective
Year: 2005
Type: article
Source: Nephrology
Institutions: Singapore General Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, Soonchunhyang University Medical Center, University Malaya Medical Centre, Chinese University of Hong Kong, Prince of Wales Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States), MSD (South Korea)
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2163639688